Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Wanders

Showing results (321-330 of 497) with videos related to

Pageof 50
Sort By:
Journal of Inherited Metabolic Disease|January 1, 1992
Zellweger syndrome in a preterm, small for gestational age infantJ F Samsom, C Jakobs, J van de Klei-van Moorsel, et al.
Journal of the Neurological Sciences|August 1, 1990
Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case reportR J Wanders, E Boltshauser, B Steinmann, et al.
Kidney International|November 1, 1996
Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluriaK J Van Acker, F J Eyskens, M F Espeel, et al.
The Journal of Biological Chemistry|May 15, 1993
The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidneyG F Vanhove, P P Van Veldhoven, M Fransen, et al.
Biochemical Pharmacology|February 14, 1995
Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line Molt-4J Cornelissen, R J Wanders, A H Van Gennip, et al.
The Journal of Clinical Investigation|March 1, 1993
Impaired degradation of leukotrienes in patients with peroxisome deficiency disordersE Mayatepek, W D Lehmann, J Fauler, et al.
Ophthalmic Paediatrics and Genetics|November 1, 1987
Peroxisomal dysfunction in chondrodysplasia punctata, rhizomelic typeJ W Oorthuys, D H Loewer-Sieger, R B Schutgens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 1999
Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"B M van Geel, J Assies, E B Haverkort, et al.
Journal of Lipid Research|January 30, 1999
Analysis of pristanic acid beta-oxidation intermediates in plasma from healthy controls and patients affected with peroxisomal disorders by stable isotope dilution gas chromatography mass spectrometryN M Verhoeven, D S Schor, E A Struys, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patientN Shimozawa, Z Zhang, A Imamura, et al.
Pageof 50

Showing results (321-330 of 497) with videos related to

Sort By:
Pageof 50
Journal of Inherited Metabolic Disease|January 1, 1992
Zellweger syndrome in a preterm, small for gestational age infantJ F Samsom, C Jakobs, J van de Klei-van Moorsel, et al.
Journal of the Neurological Sciences|August 1, 1990
Infantile phytanic acid storage disease, a disorder of peroxisome biogenesis: a case reportR J Wanders, E Boltshauser, B Steinmann, et al.
Kidney International|November 1, 1996
Hyperoxaluria with hyperglycoluria not due to alanine:glyoxylate aminotransferase defect: a novel type of primary hyperoxaluriaK J Van Acker, F J Eyskens, M F Espeel, et al.
The Journal of Biological Chemistry|May 15, 1993
The CoA esters of 2-methyl-branched chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanic acids are oxidized by one single peroxisomal branched chain acyl-CoA oxidase in human liver and kidneyG F Vanhove, P P Van Veldhoven, M Fransen, et al.
Biochemical Pharmacology|February 14, 1995
Meta-iodobenzylguanidine inhibits complex I and III of the respiratory chain in the human cell line Molt-4J Cornelissen, R J Wanders, A H Van Gennip, et al.
The Journal of Clinical Investigation|March 1, 1993
Impaired degradation of leukotrienes in patients with peroxisome deficiency disordersE Mayatepek, W D Lehmann, J Fauler, et al.
Ophthalmic Paediatrics and Genetics|November 1, 1987
Peroxisomal dysfunction in chondrodysplasia punctata, rhizomelic typeJ W Oorthuys, D H Loewer-Sieger, R B Schutgens, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 17, 1999
Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil"B M van Geel, J Assies, E B Haverkort, et al.
Journal of Lipid Research|January 30, 1999
Analysis of pristanic acid beta-oxidation intermediates in plasma from healthy controls and patients affected with peroxisomal disorders by stable isotope dilution gas chromatography mass spectrometryN M Verhoeven, D S Schor, E A Struys, et al.
Biochemical and Biophysical Research Communications|February 1, 2000
Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patientN Shimozawa, Z Zhang, A Imamura, et al.
Pageof 50